Metabolites,
Journal Year:
2024,
Volume and Issue:
15(1), P. 6 - 6
Published: Dec. 31, 2024
In
this
study,
we
present
a
novel
approach
using
amperometric
microsensors
to
detect
quercetin
in
cosmetic
formulations
and
track
its
metabolic
behavior
after
topical
application.
This
method
offers
sensitive,
real-time
alternative
conventional
techniques,
enabling
the
detection
of
quercetin’s
bioavailability,
transformation
into
active
metabolites,
potential
therapeutic
effects
when
applied
skin.
Quercetin
(Q)
is
bioactive
flavonoid
known
for
potent
antioxidant
properties,
naturally
numerous
plants,
particularly
those
with
applications
formulations.
response
growing
interest
developing
plant-based
dermo-cosmetic
solutions,
study
investigates
electrochemical
quercetin,
ketone-type
flavonoid,
extracted
from
Gingko
biloba
essential
oil.
Three
newly
designed
were
developed
assess
their
efficacy
detecting
botanical
samples.
The
sensor
configurations
utilized
two
forms
carbon
material
as
foundation:
graphite
(G)
nanoparticles
(CNs).
These
base
materials
modified
paraffin
oil,
chitosan
(CHIT),
cobalt(II)
tetraphenylporphyrin
(Co(II)TPP)
enhance
sensitivity.
Differential
pulse
voltammetry
(DPV)
served
analytical
investigation.
Among
sensors,
CHIT/G–CN
microsensor
exhibited
highest
sensitivity,
limit
1.22
×
10−7
mol
L−1,
followed
by
G–CN
(5.64
10−8
L−1)
Co(II)TPP/G–CN
(9.80
microsensors.
minimum
detectable
concentration
was
observed
CoP/G–CN
microsensors,
achieving
threshold
low
0.0001
μmol
L−1.
Recovery
rates
relative
standard
deviation
(RSD)
values
averaged
97.4%
±
0.43,
underscoring
sensors’
reliability
matrices.
European Journal of Medicinal Chemistry Reports,
Journal Year:
2024,
Volume and Issue:
11, P. 100154 - 100154
Published: April 7, 2024
Alzheimer's
disease
(AD),
the
main
dementia
type
accounting
for
over
70
%
of
entire
population,
progressive
decline
in
memory
and
executive
function.
AD
pathology
is
characterized
by
amyloid
fibrils
neurofibrillary
tangles.
Acetylcholinesterase
(AChE),
an
enzyme
involved
hydrolysis
neurotransmitter
acetylcholine,
consistently
colocalizes
with
deposits
characteristic
may
contribute
to
generation
proteins.
AChE
a
potent
amyloid-promoting
factor
when
compared
other
c-associated
inhibitors
play
vital
role
prevent
formation
toxic
oligomeric
form
peptide.
Recent
studies
have
reported
that
acetylcholinesterase
(ChE-Is)
are
present
plants,
fungi,
marine
products.
Some
cholinesterase
inhibitors,
obtained
from
plant
source
such
as
rivastigmine,
donepezil,
galantamine,
used
treatment
AD,
offer
alternative
approach
alleviate
its
symptoms
reducing
Aβ.
Due
limited
efficacy
current
drugs
there
huge
potential
phytomedicines
AD.
Medicinal
herbs
herbal
drug
preparations
traditionally
been
treat
neurological
disorders
exhibiting
anti-inflammatory
neuroprotective
properties.
Phytomedicines
containing
flavonoids,
polyphenols,
naturally
occurring
antioxidants
crosses
blood-brain
barrier
protect
neurons
oxidative
stress.
As
synthetic
drugs,
fewer
side
effects.
Therefore,
recent
research
focused
explore
develop
it
effective
In
our
review,
we
summarized
amyloid-deposition,
Acetylcholinesterase,
phytoconstituents
inhibitory
activity
treatment.
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(1), P. 126 - 126
Published: Jan. 18, 2024
Resveratrol
is
a
polyphenolic
compound
that
has
gained
considerable
attention
in
the
past
decade
due
to
its
multifaceted
therapeutic
potential,
including
anti-inflammatory
and
anticancer
properties.
However,
efficacy
impeded
by
low
water
solubility,
dose-limiting
toxicity,
bioavailability,
rapid
hepatic
metabolism.
To
overcome
these
hurdles,
various
nanoparticles
such
as
organic
inorganic
nanoparticles,
liposomes,
polymeric
dendrimers,
solid
lipid
gold
zinc
oxide
zeolitic
imidazolate
frameworks,
carbon
nanotubes,
bioactive
glass
mesoporous
were
employed
deliver
resveratrol,
enhancing
against
types
of
cancer.
Resveratrol-loaded
nanoparticle
or
resveratrol-conjugated
administration
exhibits
excellent
potency
compared
free
resveratrol.
This
review
highlights
latest
developments
nanoparticle-based
delivery
systems
for
focusing
on
potential
limitations
associated
with
compound’s
bioavailability
effectiveness.
Poultry Science,
Journal Year:
2024,
Volume and Issue:
103(3), P. 103457 - 103457
Published: Jan. 11, 2024
This
study
used
300
one-day-old,
sexless,
developing
chicks
of
Japanese
quail
to
estimate
the
ability
vitamin
C
and/or
garlic
antagonize
venomous
influence
cadmium
(Cd)
on
hematological,
immunological,
and
performance
characteristics
quail.
The
was
separated
into
five
similar
groups
60
apiece,
six
duplicates
(10
each)
were
given
each
sub-group.
control
group
received
a
basal
diet
without
any
supplements.
Cd
nourished
with
+
80
mg
chloride
(CdCl2)/kg
diet.
3rd
fed
CdCl2
/kg
complemented
200
Vitamin
(Cd+
C)/kg
4th
by
500
dried
powder
G)/kg
5th
diet,
CG)/kg
Results
showed
that
in
which
added
together
Vit
garlic,
there
an
improvement
both
live
weight
gain
(1-42
days)
feed
consumption
(1-21
&
1-42
compared
alone.
addition
alone
seems
completely
improve
cadmium-related
increase
alkaline
phosphatase
(ALP),
Aspartate
aminotransferase
(AST)
Malondialdehyde
(MDA)
levels
when
control.
Compared
cadmium-polluted
diets,
got
additives
significantly
reduced
residue.
In
addition,
group's
serum
immunoglobulin
M
(IgM)
level
decreased
significantly.
These
data
imply
dietary
supplementation
(C)
or
(G)
may
be
beneficial
retrogressing
drop
G
(IgG)
IgM
caused
minimizing
Cd's
deleterious
immunity.
Current Alzheimer Research,
Journal Year:
2024,
Volume and Issue:
21(1), P. 50 - 68
Published: Jan. 1, 2024
Acetylcholine
(ACh)
is
ubiquitously
present
in
the
nervous
system
and
has
been
involved
regulation
of
various
brain
functions.
By
modulating
synaptic
transmission
promoting
plasticity,
particularly
hippocampus
cortex,
ACh
plays
a
pivotal
role
learning
memory.
These
procognitive
actions
are
mediated
by
neuronal
muscarinic
nicotinic
cholinergic
receptors.
The
impairment
leads
to
cognitive
decline
associated
with
aging
dementia.
Therefore,
prime
focus
when
concerned
Alzheimer's
disease
(AD),
most
common
cause
In
AD,
extensive
destruction
neurons
occurs
amyloid-β
plaques
tau
protein-rich
neurofibrillary
tangles.
Amyloid-β
also
blocks
receptors
obstructs
signaling.
This
makes
central
an
important
target
for
development
drugs
AD.
fact,
centrally
acting
cholinesterase
inhibitors
like
donepezil
rivastigmine
approved
treatment
although
outcome
not
satisfactory.
identification
specific
subtypes
pathogenesis
AD
essential
develop
future
drugs.
Also,
endogenous
rescue
mechanisms
can
pave
way
new
drug
development.
this
article,
we
discussed
neuroanatomy
system.
Further,
cognition
pathophysiology
described
detail.
article
reviewed
primary
neurotransmitters
that
regulate
processes
basal
forebrain
projection
neurons.
Biotechnology Reports,
Journal Year:
2025,
Volume and Issue:
45, P. e00881 - e00881
Published: Feb. 8, 2025
Despite
broad
spectrum
utility
of
Nardostachys
jatamansi
(D.
Don)
DC,
little
is
known
about
the
molecular
processes
that
underlie
its
anti-Alzheimer
action.
To
investigate
targets
and
therapeutic
potential
N.
for
Alzheimer's
disease
(AD),
we
used
Gas
Chromatography-Mass
Spectrometry
(GC-MS),
ADMET
analysis,
network
pharmacology,
differential
gene
expression
docking,
dynamics
(MD)
simulations.
The
STITCH
database
was
creation
protein-protein
interaction
while
Cytoscape
visualization
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
pathway
enrichment
Gene
Ontology
(GO)
term
enrichment.
Additionally,
to
intermolecular
interactions
between
active
chemicals
target
proteins,
docking
experiments
were
conducted
using
Blind
on
Achilles
server.
stability
PS1
complex
with
Spirojatamol,
further
evaluated
MD
With
Spirojatamol
showing
highest
binding
energy
scores
against
(-6.9
kcal/mol),
confirmed
activity
this
metabolite
AD
formed
a
stable
at
100
nanoseconds,
according
additional
investigation
Significant
ligand-protein
verified
by
free
calculations
MM/GBSA
technique.
PS1-Spirojatamol
had
ΔG:
-36.95
±
5.00
kcal/mol.
By
focusing
several
genes
pathways,
involved
in
AD,
work
reveals
underpinnings
behind
possible
use
treatment
AD.
Research Journal of Pharmacy and Technology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 898 - 906
Published: Feb. 27, 2025
Alzheimer’s
disease
(AD)
is
an
illness
that
give
rise
to
the
degeneration
of
neurons.
It
termed
after
Dr.
Alois
Alzheimer
and
expressed
by
memory
impairment
cognitive
dysfunction.
Major
challenges
conventional
therapies
were
barriers
like
blood-brain
barrier
(BBB)
blood-cerebrospinal
fluid
(BCSFB).
Cerebrospinal
(CSF)
generated
specialised
ependymal
cells
in
choroid
plexus
(CP)
create
blood-CSF
There
are
tight
junctions
BBB
limits
paracellular
diffusion
solutes.
Moreover,
drugs
Acetylcholine
(AChE)
inhibitors
Tacrine,
Donepezil,
Galantine,
Rivastigmine
N-Methyl-D-Aspartate
(NMDA)
antagonist
Memantine
have
gastrointestinal
effects
such
as
nausea,
vomiting,
diarrhoea
other
common
adverse
effects.
NMDA
receptor-mediated
excitatory
glutamatergic
neurotransmission
essential
for
neuronal
survival
synaptic
development.
On
hand,
increased
NMDAR
activity
increases
cell
death
excitotoxicity,
which
may
be
a
contributing
factor
neurodegeneration
associated
with
Alzheimer's
(AD).
The
ever-increasing
statistics
AD
stating
up
1
crore
cases
annually
all
over
world
its
risk
factors
caused
need
preventive
measures
safe
methods
treat
disease.
involvement
free
radicals
inflammation
aetiology
suggests
antioxidant
anti-inflammatory
medicines
might
therapeutic
role.
Herbal
medications,
based
on
richness
traditional
knowledge,
useful
because
they
can
address
pathogenesis
at
numerous
places,
including
cellular
molecular
levels.
has
been
postulated
exert
their
protective
benefits
against
through
generic
activities,
well
particular
actions
AChE,
β-amyloid
fibril
production
tau
aggregation.
This
review
discusses
various
natural
herbal
alternatives
Melissa
officinalis,
Evolvus
alsinoides,
Bacopa
monnieri,
Celastrus
paniculatus,
Centella
asiatica,
etc.
prepared
using
nanotechnologies
(liposomes,
niosome,
phytosomes,
solid
lipid
nanoparticle)
found
show
rapid
efficient
absorption.
makes
it
promising
plan
future
aspects
upcoming
improvements
posing
least
toxicity
harm
human
health.
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(6), P. 788 - 788
Published: June 16, 2024
The
COVID-19
pandemic,
caused
by
infection
with
the
SARS-CoV-2
virus,
is
associated
cognitive
impairment
and
Alzheimer’s
disease
(AD)
progression.
Once
it
enters
brain,
virus
stimulates
accumulation
of
amyloids
in
brain
that
are
highly
toxic
to
neural
cells.
These
may
trigger
neurological
symptoms
COVID-19.
meningeal
lymphatic
vessels
(MLVs)
play
an
important
role
removal
toxins
mediate
viral
drainage
from
brain.
MLVs
considered
a
promising
target
prevent
COVID-19-exacerbated
dementia.
However,
there
limited
methods
for
augmentation
MLV
function.
This
review
highlights
new
discoveries
field
COVID-19-mediated
amyloid
development
strategies
stimulate
clearance
through
other
pathways.
based
on
innovative
treating
dysfunction
induced
infection,
including
use
photobiomodulation,
plasmalogens,
medicinal
herbs,
which
offer
hope
addressing
challenges
posed
virus.